Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

China flag China · Delayed Price · Currency is CNY
27.54
+0.82 (3.07%)
Apr 29, 2026, 10:55 AM CST
7.62%
Market Cap 24.63B
Revenue (ttm) 5.90B
Net Income (ttm) 1.74B
Shares Out 921.66M
EPS (ttm) 1.89
PE Ratio 14.13
Forward PE n/a
Dividend 2.09 (7.83%)
Ex-Dividend Date Jun 30, 2025
Volume 4,629,100
Average Volume 5,715,465
Open 26.92
Previous Close 26.72
Day's Range 26.75 - 27.56
52-Week Range 24.12 - 29.30
Beta 0.17
RSI 57.51
Earnings Date Apr 24, 2026

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of drugs in China. The company offers Chinese traditional and Western medicines, daily use chemicals, and medicine health products in various formulations. Its products are used in the areas of detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, hemostasis, gynecology, pneumology, gastroenterology, and geriatrics. The company is headquartere... [Read more]

Sector Healthcare
CEO Fei Cao
Employees 5,026
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600566
Full Company Profile

Financial Performance

In 2025, SHA:600566's revenue was 6.22 billion, a decrease of -22.43% compared to the previous year's 8.02 billion. Earnings were 1.78 billion, a decrease of -29.77%.

Financial Statements

News

There is no news available yet.